Cadence Pharmaceuticals, Inc., et al. v. Agila Specialties Inc., et al., C.A. No. 14-1499 – LPS, August 29, 2016.

Stark, C. J. Claim construction opinion issues regarding one term from one patent. A Markman hearing took place on June 27, 2016.

The disputed technology relates to acetaminophen formulations and methods of manufacturing. The following term was considered:

  1. “liquid formulation for intravenous administration consisting essentially of acetaminophen dispersed in an aqueous medium”